Gastro Medical News about oesophagitis

Your Unread Messages

See All

Tracy Hampton, PhD

FDA Update

Anti-CD20 Antibody Granted Accelerated Approval for CLL

Roberta Buell, MBA
2010 Part D May Hurt Low Income Patients

Dorothy J. Schirf, MD

Technology Advances

Over-the-Counter Nanotech Test for Prostate Cancer Anticipated

Sara Hartley

Technology Advances

A New Strategy for Protecting Ovaries in Young Cancer Patients

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Audit of eosinophilic oesophagitis in children post-liver transplant
Pediatric Transplantation, 11/06/09

Noble C et al. – In the 159 children who received DD OLT, 130 survived and four have been diagnosed with EE. Only 34 are currently followed in Queensland and all four patients diagnosed are in this cohort representing 12% of the follow–up clinic. Many patients are followed elsewhere so occurrence of EE in the total surviving population is an underestimate. EE is clinically important in the post–liver transplant community. Children post–OLT who have upper GI symptoms should be considered for endoscopic evaluation and biopsy to exclude EE.

<< Previous
Mechanisms and Functional Implications of Intestinal Barrier...

Next >>
MiR-122 affects the viability and apoptosis of hepatocellular...